| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cathepsin K |
|---|
| Ligand | BDBM25141 |
|---|
| Substrate/Competitor | BDBM19485 |
|---|
| Meas. Tech. | Enzyme Inhibition Assay |
|---|
| pH | 7±n/a |
|---|
| Temperature | 295.15±n/a K |
|---|
| IC50 | >10000±n/a nM |
|---|
| Citation |  Irie, O; Kosaka, T; Ehara, T; Yokokawa, F; Kanazawa, T; Hirao, H; Iwasaki, A; Sakaki, J; Teno, N; Hitomi, Y; Iwasaki, G; Fukaya, H; Nonomura, K; Tanabe, K; Koizumi, S; Uchiyama, N; Bevan, SJ; Malcangio, M; Gentry, C; Fox, AJ; Yaqoob, M; Culshaw, AJ Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain. J Med Chem51:5502-5 (2008) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Inhibition_Run data, Solution Info, Assay Method |
|---|
| |
| Cathepsin K |
|---|
| Name: | Cathepsin K |
|---|
| Synonyms: | CATK_RAT | Ctsk |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 36798.82 |
|---|
| Organism: | Rattus norvegicus |
|---|
| Description: | ChEMBL_633322 |
|---|
| Residue: | 329 |
|---|
| Sequence: | MWVFKFLLLPVVSFALSPEETLDTQWELWKKTHGKQYNSKVDEISRRLIWEKNLKKISVH
NLEASLGAHTYELAMNHLGDMTSEEVVQKMTGLRVPPSRSFSNDTLYTPEWEGRVPDSID
YRKKGYVTPVKNQGQCGSCWAFSSAGALEGQLKKKTGKLLALSPQNLVDCVSENYGCGGG
YMTTAFQYVQQNGGIDSEDAYPYVGQDESCMYNATAKAAKCRGYREIPVGNEKALKRAVA
RVGPVSVSIDASLTSFQFYSRGVYYDENCDRDNVNHAVLVVGYGTQKGNKYWIIKNSWGE
SWGNKGYVLLARNKNNACGITNLASFPKM
|
|
|
|---|
| BDBM25141 |
|---|
| BDBM19485 |
|---|
| Name | BDBM25141 |
|---|
| Synonyms: | 2-cyano-pyrropyrimidine, 7g | 7-[2-(4,4-difluorocyclohexyl)ethyl]-6-[4-(4-acetylpiperazin-1-yl)phenoxymethyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C28H32F2N6O2 |
|---|
| Mol. Mass. | 522.5895 |
|---|
| SMILES | CC(=O)N1CCN(CC1)c1ccc(OCc2cc3cnc(nc3n2CCC2CCC(F)(F)CC2)C#N)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
